Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

por Bowlus, Christopher L
Publicado 2016

The immunobiology of primary sclerosing cholangitis

por Aron, Jonathan H., Bowlus, Christopher L.
Publicado 2009

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update

por Bowlus, Christopher L., Kenney, James T., Rice, Gary, Navarro, Robert
Publicado 2016

Analysis of the IDDM Candidate Gene Prss16 in NOD and NON Mice

por Cheunsuk, Saijai, Hsu, Tom, Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2002

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

por Toy, Elaine, Balasubramanian, Sripriya, Selmi, Carlo, Li, Chin-Shang, Bowlus, Christopher L
Publicado 2011

Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist()

por Malik, Adnan, Kardashian, Ani A., Zakharia, Kais, Bowlus, Christopher L., Tabibian, James H.
Publicado 2019

Gene Expression by PBMC in Primary Sclerosing Cholangitis: Evidence for Dysregulation of Immune Mediated Genes

por Aoki, Christopher A., Dawson, Kevin, Kenny, Thomas P., Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2006

Human β-Defensin 2 in Primary Sclerosing Cholangitis

por Chang, Cindy, Lleo, Ana, Kananurak, Anchasa, Grizzi, Fabio, Tsuneyama, Koichi, Invernizzi, Pietro, Bevins, Charles L, Bowlus, Christopher L
Publicado 2017

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis

por Kowdley, Kris V., Bowlus, Christopher L., Levy, Cynthia, Mayo, Marlyn J., Pratt, Daniel S., Vuppalanchi, Raj, Younossi, Zobair M.
Publicado 2023

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale

por Levy, Cynthia, Bowlus, Christopher L., Carey, Elizabeth, Crawford, Julie M., Deane, Karen, Mayo, Marlyn J., Kim, W. Ray, Fried, Michael W.
Publicado 2018

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012

por Stewart, Susan L, Kwong, Sandy L, Bowlus, Christopher L, Nguyen, Tung T, Maxwell, Annette E, Bastani, Roshan, Chak, Eric W, Chen Jr, Moon S
Publicado 2016

Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis

por Liu, Bin, Yang, Guo-Xiang, Sun, Ying, Tomiyama, Takashi, Zhang, Weici, Leung, Patrick S. C., He, Xiao-Song, Dhaliwal, Sandeep, Invernizzi, Pietro, Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2022

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis

por Trauner, Michael, Gindin, Yevgeniy, Jiang, Zhaoshi, Chung, Chuhan, Subramanian, G. Mani, Myers, Robert P., Gulamhusein, Aliya, Kowdley, Kris V., Levy, Cynthia, Goodman, Zachary, Manns, Michael P., Muir, Andrew J., Bowlus, Christopher L.
Publicado 2019

Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study

por Eksteen, Bertus, Bowlus, Christopher L., Montano‐Loza, Aldo J., Lefebvre, Eric, Fischer, Laurent, Vig, Pamela, Martins, Eduardo Bruno, Ahmad, Jawad, Yimam, Kidist K., Pockros, Paul J., Feld, Jordan J., Minuk, Gerald, Levy, Cynthia
Publicado 2020

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with p...

por Trauner, Michael, Chung, Chuhan, Sterling, Kate, Liu, Xiangyu, Lu, Xiaomin, Xu, Jun, Tempany-Afdhal, Clare, Goodman, Zachary D., Färkkilä, Martti, Tanaka, Atsushi, Trivedi, Palak, Kowdley, Kris V., Bowlus, Christopher L., Levy, Cynthia, Myers, Robert P.
Publicado 2023

Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis

por Mazi, Tagreed A., Borkowski, Kamil, Fiehn, Oliver, Bowlus, Christopher L., Sarkar, Souvik, Matsukuma, Karen, Ali, Mohamed R., Kieffer, Dorothy A., Wan, Yu-Jui Y., Stanhope, Kimber L., Havel, Peter J., Newman, John W., Medici, Valentina
Publicado 2022

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis

por Mayo, Marlyn J., Pockros, Paul J., Jones, David, Bowlus, Christopher L., Levy, Cynthia, Patanwala, Imran, Bacon, Bruce, Luketic, Velimir, Vuppalanchi, Raj, Medendorp, Sharon, Dorenbaum, Alejandro, Kennedy, Ciara, Novak, Patricia, Gu, Joan, Apostol, George, Hirschfield, Gideon M.
Publicado 2019

Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers

por Mordaunt, Charles E., Kieffer, Dorothy A., Shibata, Noreene M., Członkowska, Anna, Litwin, Tomasz, Weiss, Karl-Heinz, Zhu, Yihui, Bowlus, Christopher L., Sarkar, Souvik, Cooper, Stewart, Wan, Yu-Jui Yvonne, Ali, Mohamed R., LaSalle, Janine M., Medici, Valentina
Publicado 2019

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study

por Bowlus, Christopher L., Eksteen, Bertus, Cheung, Angela C., Thorburn, Douglas, Moylan, Cynthia A., Pockros, Paul J., Forman, Lisa M., Dorenbaum, Alejandro, Hirschfield, Gideon M., Kennedy, Ciara, Jaecklin, Thomas, McKibben, Andrew, Chien, Elaine, Baek, Marshall, Vig, Pamela, Levy, Cynthia
Publicado 2023

A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis

por Gindin, Yevgeniy, Chung, Chuhan, Jiang, Zhaoshi, Zhou, Jing Zhu, Xu, Jun, Billin, Andrew N., Myers, Robert P., Goodman, Zachary, Landi, Abdolamir, Houghton, Michael, Green, Richard M., Levy, Cynthia, Kowdley, Kris V., Bowlus, Christopher L., Muir, Andrew J., Trauner, Michael
Publicado 2021